SPARCL1 Exhibits Different Expressions in Left- and Right-Sided Colon Cancer and is Downregulated Via DNA Methylation

References

• Ogino S , NoshoK , KirknerGJet al. CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut58(1), 90–96 (2009).
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Network . Comprehensive molecular characterization of human colon and rectal cancer. Nature487(7407), 330–337 (2012).
   PubMed Web of Science ®Google Scholar
• Li FY , LaiMD. Colorectal cancer, one entity or three. J. Zhejiang Univ. Sci. B.10(3), 219–229 (2009).
   PubMed Web of Science ®Google Scholar
• Di Pietro M , SabatesBellver J , MenigattiMet al. Defective DNA mismatch repair determines a characteristic transcriptional profile in proximal colon cancers. Gastroenterology129(3), 1047–1059 (2005).
   PubMed Web of Science ®Google Scholar
• Gao XH , YuGY , GongHFet al. Differences of protein expression profiles, KRAS and BRAF mutation, and prognosis in right-sided colon, left-sided colon and rectal cancer. Sci. Rep.7(1), 7882 (2017).
   PubMedGoogle Scholar
• Arnold D , LuezaB , DouillardJYet al. Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials. Ann. Oncol.28(8), 1713–1729 (2017).
   PubMed Web of Science ®Google Scholar
• Girard JP , SpringerTA. Cloning from purified high endothelial venule cells of hevin, a close relative of the antiadhesive extracellular matrix protein SPARC. Immunity2(1), 113–123 (1995).
   PubMed Web of Science ®Google Scholar
• Shen C , YinY , ChenHet al. Secreted protein acidic and rich in cysteine-like 1 suppresses metastasis in gastric stromal tumors. BMC Gastroenterol.18(1), 105 (2018).
   PubMedGoogle Scholar
• Claeskens A , OngenaeN , NeefsJMet al. Hevin is down-regulated in many cancers and is a negative regulator of cell growth and proliferation. Br. J. Cancer82(6), 1123–1130 (2000).
   PubMed Web of Science ®Google Scholar
• Girard JP , SpringerTA. Modulation of endothelial cell adhesion by hevin, an acidic protein associated with high endothelial venules. J. Biol. Chem.271(8), 4511–4517 (1996).
   PubMed Web of Science ®Google Scholar
• Gongidi V , RingC , MoodyMet al. SPARC-like 1 regulates the terminal phase of radial glia-guided migration in the cerebral cortex. Neuron41(1), 57–69 (2004).
   PubMed Web of Science ®Google Scholar
• Oritani K , KincadePW. Lymphopoiesis and matrix glycoprotein SC1/ECM2. Leuk. Lymphoma32(1-2), 1–7 (1998).
   PubMed Web of Science ®Google Scholar
• Naschberger E , LieblA , SchellererVSet al. Matricellular protein SPARCL1 regulates tumor microenvironment-dependent endothelial cell heterogeneity in colorectal carcinoma. J. Clin. Invest.126(11), 4187–4204 (2016).
   PubMed Web of Science ®Google Scholar
• Luo H-L , ChiangP-H , HuangC-Cet al. Methylation of SPARCL1 is associated with oncologic outcome of advanced upper urinary tract urothelial carcinoma. Int. J. Mol. Sci.20(7), 1653 (2019).
   PubMed Web of Science ®Google Scholar
• Zhao SJ , JiangYQ , XuNWet al. SPARCL1 suppresses osteosarcoma metastasis and recruits macrophages by activation of canonical WNT/beta-catenin signaling through stabilization of the WNT-receptor complex. Oncogene37(8), 1049–1061 (2018).
   PubMed Web of Science ®Google Scholar
• Hu H , ZhangH , GeWet al. Secreted protein acidic and rich in cysteines-like 1 suppresses aggressiveness and predicts better survival in colorectal cancers. Clin. Cancer. Res.18(19), 5438–5448 (2012).
   PubMed Web of Science ®Google Scholar
• Cerami E , GaoJ , DogrusozUet al. The cBio cancer genomics portal, an open platform for exploring multidimensional cancer genomics data. Cancer Discov.2(5), 401–404 (2012).
   PubMed Web of Science ®Google Scholar
• Hu H . Study of novel tumor metastasis-related gene SPARCL1 [PhD dissertation]. Zhejiang University, Hangzhou, China (2010).
   Google Scholar
• Nakamura Y , HokutoD , KoyamaFet al. The prognosis and recurrence pattern of right- and left-sided colon cancer in Stage II, Stage III, and liver metastasis after curative resection. Ann. Coloproctol. doi:10.3393/ac.2020.09.14 (2020) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Shida D , InoueM , TanabeTet al. Prognostic impact of primary tumor location in Stage III colorectal cancer-right-sided colon versus left-sided colon versus rectum, a nationwide multicenter retrospective study. J. Gastroenterol.55(10), 958–968 (2020).
   PubMed Web of Science ®Google Scholar
• Hu H , CaiW , ZhengS , GeW. SPARCL1, a novel prognostic predictive factor for GI malignancies, a meta-analysis. Cell Physiol. Biochem.44(4), 1485–1496 (2017).
   PubMedGoogle Scholar
• Ge W , HuH , CaiWet al. High-risk Stage III colon cancer patients identified by a novel five-gene mutational signature are characterized by upregulation of IL-23A and gut bacterial translocation of the tumor microenvironment. Int. J. Cancer146(7), 2027–2035 (2020).
   PubMed Web of Science ®Google Scholar
• Schubeler D . Function and information content of DNA methylation. Nature517(7534), 321–326 (2015).
   PubMed Web of Science ®Google Scholar
• Yin Y , MorgunovaE , JolmaAet al. Impact of cytosine methylation on DNA binding specificities of human transcription factors. Science356(6337), e2239 (2017).
   Web of Science ®Google Scholar
• Brenet F , MohM , FunkPet al. DNA methylation of the first exon is tightly linked to transcriptional silencing. PLoS ONE6(1), e14524 (2011).
   PubMed Web of Science ®Google Scholar
• Bormann F , Rodriguez-ParedesM , LasitschkaFet al. Cell-of-origin DNA methylation signatures are maintained during colorectal carcinogenesis. Cell Rep.23(11), 3407–3418 (2018).
   PubMed Web of Science ®Google Scholar
• Gallois C , Laurent-PuigP , TaiebJ. Methylator phenotype in colorectal cancer: a prognostic factor or not?Crit. Rev. Oncol. Hematol.99, 74–80 (2016).
   PubMed Web of Science ®Google Scholar
• Hurley PJ , HughesRM , SimonsBWet al. Androgen-regulated SPARCL1 in the tumor microenvironment inhibits metastatic progression. Cancer Res.75(20), 4322–4334 (2015).
   PubMed Web of Science ®Google Scholar
• Wu DM , ShiJ , LiuT , DengSH , HanR , XuY. Integrated analysis reveals down-regulation of SPARCL1 is correlated with cervical cancer development and progression. Cancer Biomark.21(2), 355–365 (2018).
   PubMed Web of Science ®Google Scholar
• Taieb J , KourieHR , EmileJFet al. Association of prognostic value of primary tumor location in stage III colon cancer with RAS and BRAF mutational status. JAMA Oncol.4(7), e173695 (2018).
   PubMed Web of Science ®Google Scholar
• Song K , ZhaoW , WangW , ZhangN , WangK , ChangZ. Individualized predictive signatures for 5-fluorouracil-based chemotherapy in right- and left-sided colon cancer. Cancer Sci.109(6), 1939–1948 (2018).
   PubMed Web of Science ®Google Scholar
• Nawa T , KatoJ , KawamotoHet al. Differences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histology. J. Gastroenterol. Hepatol.23(3), 418–423 (2008).
   PubMed Web of Science ®Google Scholar
• Missiaglia E , JacobsB , D’ArioGet al. Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features. Ann. Oncol.25(10), 1995–2001 (2014).
   PubMed Web of Science ®Google Scholar
• Deng G , KakarS , TanakaHet al. Proximal and distal colorectal cancers show distinct gene-specific methylation profiles and clinical and molecular characteristics. Eur. J. Cancer44(9), 1290–1301 (2008).
   PubMed Web of Science ®Google Scholar
• Maus MK , HannaDL , StephensCLet al. Distinct gene expression profiles of proximal and distal colorectal cancer, implications for cytotoxic and targeted therapy. Pharmacogenom. J.15(4), 354–362 (2015).
   PubMed Web of Science ®Google Scholar
• Sanz-Garcia E , ArgilesG , ElezE , TaberneroJ. BRAF mutant colorectal cancer, prognosis, treatment, and new perspectives. Ann. Oncol.28(11), 2648–2657 (2017).
   PubMed Web of Science ®Google Scholar
• Cremolini C , AntoniottiC , LonardiSet al. Primary tumor sidedness and benefit from FOLFOXIRI plus bevacizumab as initial therapy for metastatic colorectal cancer. Retrospective analysis of the TRIBE trial by GONO. Ann. Oncol.29(7), 1528–1534 (2018).
   PubMed Web of Science ®Google Scholar
• Clara Tenkerian DR , VictoriaL , AnikaKet al. SPARCL1 is an angiocrine inhibitor of tumorigenesis in colorectal carcinoma. Proceedings of: AACR Annual Meeting 2019.Atlanta, GA, USA, 29 March–3 April 2019 ( Abstract 30).
   Google Scholar
• Isler SG , LudwigCU , Chiquet-EhrismannR , SchenkS. Evidence for transcriptional repression of SPARC-like 1, a gene downregulated in human lung tumors. Int. J. Oncol.25(4), 1073–1079 (2004).
   PubMed Web of Science ®Google Scholar
• Yan H , GuanQ , HeJet al. Individualized analysis reveals CpG sites with methylation aberrations in almost all lung adenocarcinoma tissues. J. Transl. Med.15(1), 26 (2017).
   PubMedGoogle Scholar
• Zhu H , WangG , QianJ. Transcription factors as readers and effectors of DNA methylation. Nat. Rev. Genet.17(9), 551–565 (2016).
   PubMed Web of Science ®Google Scholar
• Banskota S , DahalS , KwonE , KimDY , KimJA. β-Catenin gene promoter hypermethylation by reactive oxygen species correlates with the migratory and invasive potentials of colon cancer cells. Cell Oncol. (Dordr.)41(5), 569–580 (2018).
   PubMed Web of Science ®Google Scholar
• Chen C , WangB , SunJet al. DAC can restore expression of NALP1 to suppress tumor growth in colon cancer. Cell Death Dis.6(1), e1602 (2015).
   PubMedGoogle Scholar